Our Services
Strategic Advisory and Partnership Support for Growth-Stage Healthcare Innovators
OGAdvisors specializes in partnerships and transactions across the healthcare technology spectrum, serving pharmaceuticals, diagnostics, medical devices, and healthcare services clients. The team provides various advisory services such as partnership creation, early-stage fundraising, business and go-to-market strategy, modeling and valuation, term sheet negotiations and transaction support.
Our fractional business development model allows executive teams to appropriately focus on growing their core business, while advancing strategic partnerships that can provide funding, resources, credibility and market access.
OGAdvisors primarily focuses on smaller and middle-market med-tech and biotech companies trying to grow through strategic partnerships and fundraising.
We have flexible engagement models and have previously co-invested in select transactions.
Our Advantage
OGAdvisors’ team consist of business development, marketing and strategy professionals, as well as financial analysts, project managers and subject-matter experts. For a fraction of one FTE, the entire team is available on an as-needed basis.
OGA’s network consists of hundreds of business development executives at large and mid-sized pharmaceutical and medical device companies. We are familiar with the interplays between scouting, search & evaluation, business development and alliance management departments, and navigate the maze to interest the right persons and provide our clients with a fair shot at pitching their opportunity. We also maintain databases that monitor the changing priorities of would-be partners, and the movements of these executives between companies.
OGA’s flexible engagement also means you can scale up or down our involvement as your business needs change or in between data readouts.
Services
OGAdvisors provides substantial added value whether clients are at the beginning of their partnering journey, or already have existing relationships
Positioning
Maximizing attractiveness to potential partners
Identification
Determining, stratifying and prioritizing partners
Outreach
Getting to the right person at the right company
Cadence
Controlling the pace of the outreach process
Term Sheet
Negotiating based on aligned models and incentives
Positioning
An engagement begins with an assessment of the client’s programs, data, development path and options for progress. We work with clients to position their pitch decks for maximum impact, including customizing decks for different audiences. We also benchmark against current market dynamics, competing programs and alternative platform. Last, we also provide an objective assessment of the strength of the data to date, from the viewpoint of a potential licensee.
Identification
OGA maintains a knowledge base of potential pharma partners. These are segmented by disease area, target, and asset stage. We also research related programs and identify similar efforts at potential licensees. We then create bespoke outreach packages that match a client’s offering to the specific priorities set by the potential pharma partner.
Outreach
Prospective pharma licensees are uniquely structured. Some maintain central search and evaluation departments, while others have distributed models, based on disease areas. Some companies evaluate early-stage candidates on an opportunistic basis, while other companies prioritize licensing based on multi-year strategic directives. In addition, business development executives frequently transition between companies. It is a daunting maze of possible relationships. With our previous relationships and connections, we make sure that our clients have a fair shot at presenting the promise of their programs.
Cadence
As a lifeciences CEO, you juggle multiple roles, including managing the lab, external vendors such as CROs and CDMOs, the budget, grant submission and countless unexpected issues that seem to arise daily. As a result, business development conversations sometimes are adversely impacted: you forget to send an update to an interested prospective investors; an email requesting more information goes unanswered, a referral email isn’t followed up on. OGA leads a business development process that is at once transparent and structured, using advanced B2B sales tools such as CRMs and automation to assure that any opportunity is acted on.
Term Sheet
When a prospective partner advances to confidential negotiations and terms are discussed, OGA assigns a project manager to manage the project seamlessly:
- Data room creation and maintenance
- Market models buildout using our proprietary tool, the pharma asset valuation tool
- Coordination of various teams (such as IP, HR, regulatory, quality) as counter-parts for due diligence
- Timely management of questions and responses
- Collaboration with legal teams on drafting definitive documents
- Design of integration plans that align client and partner priorities